Clinical Trials in Pittsburgh

Showing 2141-2160 of 10,050 trials

An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant

NCT06832410

This study will evaluate the efficacy, safety, and tolerability of VX-880 in participants with Type 1 Diabetes (TID) with a kidney transplant.

Type 1 DiabetesKidney Transplant

Vertex Pharmaceuticals Incorporated10 participantsStarted Mar 2025

Philadelphia, Pennsylvania, United States • Pittsburgh, Pennsylvania, United States • Madison, Wisconsin, United States +4 more locations

COMPLETEDPhase 3< 1 mile

A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial

NCT04847557

The main purpose of this study is to assess the efficacy and safety of Tirzepatide (LY3298176) in participants with heart failure with preserved ejection fraction and obesity.

ObesityHeart Failure With Preserved Ejection Fraction (HFpEF)

Eli Lilly and Company731 participantsStarted Apr 2021

Huntsville, Alabama, United States • Beverly Hills, California, United States • Covina, California, United States +143 more locations

An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant

A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial

Find Trials by Condition in Pittsburgh

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec

Defining the Genetic Etiology of Suppurative Lung Disease in Children and Adults

PTG-300 in Subjects With Hereditary Hemochromatosis

A Phase 2 Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (CITADEL-202)

Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas

Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine, LID/ΔM2-2/1030s, in RSV-Seronegative Infants and Children 6 to 24 Months of Age

Study to Assess AFM24 in Combination With Atezolizumab in Selected Advanced/Metastatic EGFR-expressing Cancers

ERG Components in Schizophrenia and Bipolar Disorder Type I

A Proof-of-concept Study of the Efficacy and Safety of Nipocalimab in Participants With Active Rheumatoid Arthritis

STICH3C Cardiac Magnetic Resonance Observational Study

Characterizing the Upper Airway Manifestations in Primary Ciliary Dyskinesia and Primary Immunodeficiencies

[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer

A Study Assessing KB407 for the Treatment of Cystic Fibrosis

A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis

INCB050465 in Combination With Rituximab, Bendamustine and Rituximab, or Ibrutinib in Participants With Previously Treated B-Cell Lymphoma (CITADEL-112)

Families Left Behind

The ReTAVI Prospective Observational Registry